Drug Discovery and Therapy

National Cancer Institute (NCI) provides preclinical cancer research, which includes evaluating the preclinical safety and pharmacokinetics of chemotherapeutics and chemopreventive agents. Many research Laboratories also provides genetic toxicology testing for NCI's chemoprevention program, synthesizes compounds for NCI's carcinogen repository, and manufactures clinical trial materials.

National Cancer Institute (NCI) funded for Tumour Glycome Laboratories. They are the principal component of the trans-NIH Alliance of Glycobiologists for Detection of Cancer and Cancer Risk, which is searching for glycan-based biomarkers for breast, ovarian, lung, prostate and pancreatic cancers and melanoma.

More than 30 years of research has led to numerous drugs on the market or ready for licensing, including:

·         Targretin® (bexarotene), a retinoid receptor ligand marketed by Eisai

·         Tirapazamine, a hypoxic tissue-selective cytotoxin

·         TAS-108, a selective estrogen receptor modulator licensed to Taiho Pharmaceutical

·         PDX (pralatrexate), an antimetabolite licensed to Allos Therapeutics

·         SR16157, a dual estrone sulfatase / ER antagonist for breast cancer treatment

The discovery and development of small molecule cancer drugs has been revolutionised over the last decade. Most notably, we have moved from a one-size-fits-all approach that emphasized cytotoxic chemotherapy to a personalised medicine strategy that focuses on the discovery and development of molecularly targeted drugs that exploit the particular genetic addictions, dependencies and vulnerabilities of cancer cells.

  • Anti-Cancer Drug Discovery and Therapy
  • CVS Drug Discovery and Therapy
  • Innovative Drug Discovery and Nanotechnology
  • Anti-Infectives Drug Discovery and Therapy
  • CNS Drug Discovery and Therapy
  • Anti- Diabetic Drug Discovery and Therapy
  • Application of Nanotechnology in Pharmaceutical Formulation Design and Development

Related Conference of Drug Discovery and Therapy

(10 Plenary Forums-1Event)
November 02-03, 2017

18th World Conference and Exhibition on Analytical & Bioanalytical Chromatographic Techniques

Atlanta, Georgia, USA
November 15-16, 2017

2nd International Conference on Nuclear Chemistry

(10 Plenary Forums - 1Event)
Las Vegas, Nevada, USA
March 01 - 03, 2018

4th European Organic Chemistry Congress


Chemistry & Drug Discovery 2018

Mexico City, Mexico
May 17-19, 2018

11th Global Experts Meeting on Chemistry

July 23-24, 2018 Lisbon, Portugal

9th Global Chemistry Congress

8th European Chemistry Congress

June 21-23, 2018 Paris, France
October 29-30, 2018

3rd International Conference on Pharmaceutical Chemistry

Brussels, Belgium
October 22-23 , 2018

24th World Chemistry & System Biology Conference

Toronto,Ontario, Canada
November 05-06, 2018

International Conference on Catalysis and Pyrolysis 2018 (ICCP-2018)

(10 Plenary Forums - 1Event)
San Francisco, USA

Drug Discovery and Therapy Conference Speakers